WHO Press Conference On Potential Mpox Emergency Declaration Begins
Portfolio Pulse from Benzinga Newsdesk
The World Health Organization (WHO) has begun a press conference to discuss the potential declaration of an emergency regarding the Mpox virus. This could have significant implications for companies involved in the development of vaccines and treatments for the virus.
August 14, 2024 | 5:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aethlon Medical (AEMD) could see increased interest and potential stock price movement due to its involvement in developing treatments for viral infections, including Mpox.
AEMD is involved in developing treatments for viral infections, and a WHO emergency declaration could increase demand for their products.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Chimerix (CMRX) could experience a positive impact on its stock price due to its work on antiviral treatments, which may become more critical if Mpox is declared an emergency.
CMRX's antiviral treatments could see increased demand if Mpox is declared an emergency by WHO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
GeoVax Labs (GOVX) may see a positive impact on its stock price due to its involvement in developing vaccines for viral infections, including Mpox.
GOVX's work on vaccines for viral infections could become more critical if Mpox is declared an emergency.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Inovio Pharmaceuticals (INO) could benefit from increased attention and potential stock price movement due to its work on DNA-based vaccines, including those for viral infections like Mpox.
INO's DNA-based vaccines for viral infections could see increased demand if Mpox is declared an emergency.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Moderna (MRNA) may experience a positive impact on its stock price due to its expertise in mRNA vaccines, which could be crucial if Mpox is declared an emergency.
MRNA's mRNA vaccine technology could become more critical if Mpox is declared an emergency.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
SIGA Technologies (SIGA) could see a positive impact on its stock price due to its work on antiviral treatments, which may become more critical if Mpox is declared an emergency.
SIGA's antiviral treatments could see increased demand if Mpox is declared an emergency by WHO.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Tonix Pharmaceuticals (TNXP) may see a positive impact on its stock price due to its involvement in developing treatments for viral infections, including Mpox.
TNXP's work on treatments for viral infections could become more critical if Mpox is declared an emergency.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70